Our findings collectively define how cytokines contribute directly to cachexia-associated adipose wasting through STAT3-dependent transcriptional changes that ultimately increase adipocyte lipolysis through ATGL and CGI-58 activity, providing new potential targets to suppress cancer cachexia. The gene discussed is PNPLA2; the disease is Cachexia.